Skip to main content

Table 1 Baseline characteristics

From: Prevalence of non-alcoholic fatty liver disease and its associated factors in individuals with type 1 diabetes: a cross-sectional study in a tertiary care center in Brazil

N

95

Age, years

39 ± 13

Female, n (%)

55 (57.9)

Self-reported color-race, n (%)

Caucasian

47 (49.5)

Black

16 (16.8)

Brown

32 (33.7)

Years of formal education

12 ± 3

Diabetes duration, years

21 ± 9

Overweight, n (%)

31 (32.6)

Obesity, n (%)

14 (14.7)

Metabolic syndrome, n (%)

42 (44.2)

Steatosis on ultrasound, n (%)

12 (12.6)

Steatosis on TE, n (%)

16 (16.8)

 ≥ S1

13 (12.6)

 ≥ S2

0 (0)

 ≥ S3

3 (3.2)

Steatosis on ultrasound + TE

5 (5.3)

Fibrosis ≥ F2 on TE, n (%)

8 (8.4)

F2

3 (3.1)

F3

3 (3.1)

F4

2 (2.1)

Categories of FLI, n (%)

High risk

Undetermined risk

Low risk

16 (16.8%)

16 (16.8%)

63 (66.3%)

HbA1c (%) (mmol/mol)

8.6 [2.1]

70 [24]

  1. Data are represented as means ± standard deviation, median [interquartile range] or as numbers (percentages); TE: transient elastography; FLI: fatty liver index; HbA1c: glycated hemoglobin. ≥ S1, ≥ S2, ≥ S3 correspond to stages of steatosis and F2, F3 and F4 correspond to stages of fibrosis, determined by TE